Aktis Oncology Inc.
AKTS | NASDAQ
$15.93
-$0.92 (-5.46%)
At close: Oct 30, 2026, 4:00 PM ET
$15.90
-$0.03 (-0.19%)
Pre-market:
Nov 2, 2026, 8:53 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | 6.5M | 1.49M | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | 6.5M | 1.49M | n/a | n/a |
Operating Income | -74.68M | -52.05M | -34.79M | -19.76M |
Interest Income | 11.01M | 8.1M | 5.38M | 1.65M |
Pretax Income | -63.73M | -43.98M | -28.64M | -17.93M |
Net Income | -63.73M | -43.98M | -28.64M | -17.93M |
Selling & General & Admin | 12.6M | 11.31M | 7.68M | 5.11M |
Research & Development | 67.45M | 40.95M | 25.92M | 14.3M |
Other Expenses | 1.13M | 1.28M | 1.2M | 356K |
Operating Expenses | 81.18M | 53.54M | 34.79M | 19.76M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 81.18M | 53.54M | 34.79M | 19.76M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 52.52M | 34.86M | 34.86M | 34.86M |
Shares Outstanding (Diluted) | 52.52M | 34.86M | 34.86M | 34.86M |
EPS (Basic) | -1.19 | -1.26 | -0.82 | -0.51 |
EPS (Diluted) | -1.19 | -1.26 | -0.82 | -0.51 |
EBITDA | -61.4M | -42.41M | -27.52M | -17.48M |
EBIT | -63.73M | -43.98M | -28.64M | -17.93M |
Depreciation & Amortization | 2.33M | 1.58M | 1.12M | 445K |
Add to Watchlist
Select watchlists to add or remove AKTS